Document is current

Article History

Accepted: 17 December 2025

First Online: 13 January 2026

Declarations

:

: This article does not contain any studies with human or animal subjects performed by any of the authors.

: AL has received research support from Novo Nordisk, speaker honoraria from Astra Zeneca, Elpen. Novo Nordisk, Menarini Phasmaserve-Lilly and Sanofi and support for attending meetings and travel from Novo Nordisk, Menarini, Sanofi and Vianex, outside the submitted work. AL is the section editor for the Pharmacologic Treatment of Type 2 Diabetes section in Current Diabetes Reports. TK declares no relationships or activities that might bias, or be perceived to bias, this work. IA has received research support from Novo Nordisk, outside the submitted work. EB has received research support from Novo Nordisk and speaker honoraria from Menarini and Sanofi, outside the submitted work.